Aridis Pharmaceuticals In...
(ARDS)
undefined
undefined%
At close: undefined
0.00
-99.00%
Pre-market Oct 07, 2024, 09:30 AM EDT
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Revenue | n/a | n/a | 1.00M | 1.02M | 2.76M | 860.00K | 2.27M |
| Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 1.93M |
| Gross Profit | n/a | n/a | 1.00M | 1.02M | 2.76M | 860.00K | 342.00K |
| Operating Income | -29.99M | -43.71M | -22.40M | -29.09M | -24.12M | -19.74M | -7.88M |
| Interest Income | n/a | n/a | 77.00K | 357.00K | n/a | 234.00K | n/a |
| Pretax Income | -30.37M | -43.19M | -22.33M | -29.68M | -22.11M | -24.66M | -8.42M |
| Net Income | -30.75M | -42.28M | -21.92M | -28.99M | -22.11M | -24.66M | -8.42M |
| Selling & General & Admin | 7.16M | 7.31M | 6.45M | 6.03M | 3.87M | 3.16M | 1.97M |
| Research & Development | 25.92M | 37.94M | 16.96M | 24.08M | 23.00M | 17.44M | 6.26M |
| Other Expenses | -3.09M | -1.53M | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 29.99M | 43.71M | 23.40M | 30.11M | 26.87M | 20.60M | 8.23M |
| Interest Expense | 378.00K | -245.00K | n/a | n/a | 420.00K | n/a | 366.00K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 29.99M | 43.71M | 23.40M | 30.11M | 26.87M | 20.60M | 10.15M |
| Income Tax | 378.00K | -912.00K | -414.00K | -695.00K | 2.43M | 4.92M | 538.00K |
| Shares Outstanding (Basic) | 18.78M | 12.29M | 9.17M | 8.46M | 3.15M | 7.89M | 7.89M |
| Shares Outstanding (Diluted) | 18.78M | 12.29M | 9.17M | 8.46M | 3.15M | 7.89M | 7.89M |
| EPS (Basic) | -1.64 | -3.44 | -2.39 | -3.43 | -7.02 | -3.12 | -1.07 |
| EPS (Diluted) | -1.64 | -3.44 | -2.39 | -3.43 | -7.02 | -3.12 | -1.07 |
| EBITDA | -29.51M | -44.43M | -22.06M | -28.75M | -23.83M | -19.68M | -7.86M |
| Depreciation & Amortization | 487.00K | -722.00K | 337.00K | 338.00K | 283.00K | 62.00K | 23.00K |